These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15724622)

  • 1. [Use of recombinant activated factor VII (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage].
    Vyhovs'ka IaI; Karol' IuS; Fedak LM; Tsytsyk OI
    Lik Sprava; 2004; (7):77-81. PubMed ID: 15724622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura.
    Baxter MS; Schroeder WS; Cheng Y; Bernstein ZP
    Ann Pharmacother; 2006 Nov; 40(11):2053-8. PubMed ID: 17062831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.
    Wróbel G; Dobaczewski G; Patkowski D; Sokół A; Grotthus E
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):729-30. PubMed ID: 16933258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
    Poon MC
    Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization.
    Savani BN; Dunbar CE; Rick ME
    Am J Hematol; 2006 Mar; 81(3):218-9. PubMed ID: 16493611
    [No Abstract]   [Full Text] [Related]  

  • 7. Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
    Kessler C
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S228-34. PubMed ID: 12404091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant factor VIIa in a thrombocytopenic patient with spontaneous intracerebral haemorrhage.
    Busani S; Marietta M; Pasetto A; Girardis M
    Thromb Haemost; 2005 Feb; 93(2):381-2. PubMed ID: 15711759
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant activated factor VII (rFVIIa, NovoSeven).
    Agarwal MB; Patnaik M
    J Assoc Physicians India; 2005 Aug; 53():717-20. PubMed ID: 16398083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
    Payne EM; Brett SJ; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):397-402. PubMed ID: 16788316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing NovoSeven trials.
    Erhardtsen E
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
    Barnes C; Blanchette V; Canning P; Carcao M
    Transfus Med; 2005 Apr; 15(2):145-50. PubMed ID: 15859982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
    Grinţescu I; Tulbure D; Mirea L
    Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant factor VIIa (Novoseven) as a hemostatic agent.
    Hedner U
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):43-7. PubMed ID: 11735110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
    Grounds M
    Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor VIIa (NovoSeven) as a hemostatic agent.
    Hedner U
    Dis Mon; 2003 Jan; 49(1):39-48. PubMed ID: 12525827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of "NovoSeven" (rFVIIa) hemostatic in patients operated with extracorporeal blood circulation].
    Dement'eva II; Sandrikov VA; Charnaia MA; Morozov IuA; Trekova NA; Eremenko AA
    Anesteziol Reanimatol; 2004; (5):11-3. PubMed ID: 15573716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.